Malignant Hypertension with Thrombotic Microangiopathy

Area of Science:

• Nephrology
• Hematology
• Internal Medicine

Background:

• Thrombotic microangiopathy (TMA) is a rare condition characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ damage.
• Malignant hypertension can mimic or trigger TMA, presenting diagnostic challenges.

Observation:

• A 49-year-old male presented with malignant hypertension, acute kidney injury, and mental deterioration.
• Initial findings included microangiopathic hemolytic anemia, thrombocytopenia, and kidney damage, suggestive of TMA.
• The patient's condition was initially attributed to malignant hypertension, delaying plasma therapy.

Findings:

• High platelet counts and serum creatinine levels were identified as predictors of severe ADAMTS13 deficiency.
• The patient experienced a full recovery following treatment with antihypertensive drugs and intermittent hemodialysis.
• This outcome suggests that TMA secondary to malignant hypertension may not always require plasma therapy.

Implications:

• Accurate differential diagnosis is crucial for appropriate TMA management.
• Antihypertensive therapy and supportive care, such as hemodialysis, can be effective for TMA secondary to malignant hypertension.
• This case provides valuable insights into the diagnosis and treatment of TMA in the context of severe hypertension.